 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/18/2024 |
$3.12 |
$3.24 |
$3.12 |
$3.21 |
226.80K | | 04/19/2024 |
$3.19 |
$3.29 |
$3.17 |
$3.23 |
176.60K | | 04/22/2024 |
$3.23 |
$3.29 |
$3.12 |
$3.15 |
205.90K | | 04/23/2024 |
$3.16 |
$3.24 |
$3.11 |
$3.20 |
110.60K | | 04/24/2024 |
$3.18 |
$3.22 |
$3.11 |
$3.15 |
113.10K |
|
|
| Ovid Therapeutics is a biopharmaceutical company focus on reducing seizures and epilepsies and seizure-related neurological disorders. Co.'s pipeline has produced two epilepsy programs with potential mechanisms of action (MoA), and one epilepsy program with a potential MoA. These programs include soticlestat, which is a cholesterol 24 hydroxylase inhibitor. OV350 is a potential direct activator of the K-Cl co-transporter (KCC2) transporter, and is one among many KCC2 activator compounds in its portfolio. OV329 is a GABA aminotransferase inhibitor. Co.'s genetic research programs include OV815, which focuses on the mutations associated with KIF1A-associated neurological disorder. | |
|
Ovid Therapeutics (OVID) has the following price history information. Looking back at OVID historical stock prices for the last five trading days, on April 18, 2024, OVID opened at $3.12, traded as high as $3.24 and as low as $3.12, and closed at $3.21. Trading volume was a total of 226.80K shares. On April 19, 2024, OVID opened at $3.19, traded as high as $3.29 and as low as $3.17, and closed at $3.23. Trading volume was a total of 176.60K shares. On April 22, 2024, OVID opened at $3.23, traded as high as $3.29 and as low as $3.12, and closed at $3.15. Trading volume was a total of 205.90K shares. On April 23, 2024, OVID opened at $3.16, traded as high as $3.24 and as low as $3.11, and closed at $3.20. Trading volume was a total of 110.60K shares. On April 24, 2024, OVID opened at $3.18, traded as high as $3.22 and as low as $3.11, and closed at $3.15. Trading volume was a total of 113.10K shares.
OVID Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Ovid Therapeutics shares, starting with a $10,000 purchase of OVID, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
05/08/2017 |
|
| End date: |
04/24/2024 |
|
| Start price/share: |
$12.79 |
|
| End price/share: |
$3.15 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-75.37% |
|
| Average Annual Total Return: |
-18.22% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$2,462.64 |
|
| Years: |
6.97 |
|
|
|
| Date |
Close |
| 04/18/2024 | $3.21 | | 04/19/2024 | $3.23 | | 04/22/2024 | $3.15 | | 04/23/2024 | $3.20 | | 04/24/2024 | $3.15 |
|
|
Free OVID Email Alerts:
